InterCommunity Cancer Center, a radiation oncology practice in The US Oncology Network, treats a variety of cancers using state of the art technology to achieve the best possible outcome for each patient.
ICCC is helping to pioneer a new tool proven to protect prostate cancer patients from the negative effects of radiation therapy. SpaceOAR hydrogel is the first FDA-cleared spacing device to protect the rectum in men undergoing radiation therapy for prostate cancer. Watch this video and learn more.
InterCommunity Cancer Center physicians and staff are dedicated to delivering the highest level of coordinated compassionate care while offering support to their families. We partner with our patients primary care physicians and specialists, ensuring our patients’ entire care team understands the prescribed treatment and is continuously updated on their patient’s progress.
As part of The US Oncology Network, ICCC is part of a community of more than 1,400 independent physicians dedicated to delivering value-based, integrated care for patients — close to home. The Network practices have more than 400 sites of care in over 25 states and treat over 850,000 patients annually.